Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2017-05-01
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Low Sensitivity Pregnancy Test for Self-assessment of Medical Abortion
NCT02231619
Medication Abortion With Autonomous Self-Assessment Project
NCT05278780
Home Follow-up After Medication Abortion
NCT04304365
Routine Follow-up Versus Self-assessment in Medical Abortion
NCT01487213
MA-ASAP at Independent Abortion Clinics: A Demonstration Project
NCT05781061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multi-level pregnancy test (MLPT)
Patients randomized to multi-level pregnancy test (MLPT) arm will receive MLPTs to perform at home one and two weeks after taking mifepristone. They will be asked to interpret the results of the MLPT as it relates to their pregnancy termination status.
Self-assessment: MLPT
Patients enrolled in the study will self-assess the outcomes of their medical abortion using the multi-level pregnancy test.
Low sensitivity pregnancy test (LSPT)
Patients randomized to low sensitivity pregnancy test (LSPT) arm will receive LSPTs to perform at home at one and two weeks after taking mifepristone. They will be asked to interpret the results of the LSPT as it relates to their pregnancy termination status.
Self-assessment: LSPT
Patients enrolled in the study will self-assess the outcomes of their medical abortion using the low sensitivity pregnancy test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-assessment: MLPT
Patients enrolled in the study will self-assess the outcomes of their medical abortion using the multi-level pregnancy test.
Self-assessment: LSPT
Patients enrolled in the study will self-assess the outcomes of their medical abortion using the low sensitivity pregnancy test.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking
* Determined by the site investigator or designee to be fully eligible for medical abortion with mifepristone followed by misoprostol according to the site's standard criteria
* In the judgement of the site investigator, she is capable of giving informed consent and she has signed the study informed consent or assent form
Exclusion Criteria
* Non-english speaking
* Inability to access internet
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford Health Care
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
39816
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.